Hansen's disease, formerly known as leprosy, is a chronic infectious disease caused by the bacteria Mycobacterium leprae. This disease primarily affects the skin, nerves, and mucous membranes, leading to skin lesions, nerve damage, and disfigurement if left untreated.

Hansen's disease is named after the Norwegian physician Gerhard Armauer Hansen, who first identified the bacteria responsible for the disease in 1873. Despite being curable with multidrug therapy, Hansen's disease continues to be stigmatized in many parts of the world, leading to discrimination and social exclusion for those affected.

Early symptoms of Hansen's disease include skin lesions that may be discolored, raised, or flat. As the disease progresses, nerve damage can lead to loss of sensation in the affected areas, as well as muscle weakness and paralysis. In severe cases, deformities such as clawed hands or feet may develop.

Diagnosis of Hansen's disease is typically based on clinical symptoms and a skin biopsy to confirm the presence of the bacteria. Treatment involves a combination of antibiotics, usually dapsone, rifampicin, and clofazimine, taken for a period of six months to two years, depending on the severity of the disease.

It is important to seek medical attention if you suspect you may have Hansen's disease, as early diagnosis and treatment can prevent complications and reduce the risk of transmission to others. With proper care, most people with Hansen's disease can be cured and lead normal, productive lives.

For more information on Hansen's disease, visit the World Health Organization's website at https://www.who.int/news-room/fact-sheets/detail/leprosy. If you have concerns about your symptoms or need to find a healthcare provider, consult the National Hansen's Disease Program at https://www.hrsa.gov/hansens-disease/index.html.

Sign Up